Znn3bq.jpeg
²é¿´: 1056  |  »Ø¸´: 11
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

florencehao

гæ (СÓÐÃûÆø)

[½»Á÷] ÕÐÆ¸±í¹ÛÒÅ´«Ñ§

¾ßÌ幤×÷µØµã:
ÉϺ£
н½ð:
1Íò2×óÓÒ
ѧÀúºÍÑо¿·½Ïò:
ÖÁÉÙ˶ʿ
ÕÐÆ¸¸Úλ:
¿ÆÑ§¼Ò
¹«Ë¾Ãû³Æ:
ÉϺ£ÕŽ­Ò©³§
¹«Ë¾ÍøÖ·:
www.21cnmanager.com
ÁªÏµ·½Ê½:
021 3122 9017 or florencehao@21cnmanager.com

ÕÐÆ¸±í¹ÛÒÅ´«Ñ§£¬ÒªÇóÓ¢ÓïºÃ£¬ ÕÆÎÕ·Ö×ÓºÍϸ°ûÉúÎïѧ¼¼Êõ£¬


The qualified candidate will utilize the cutting-edge biological technologies to identify and validate the disease-relevantgenetic/epigenetic regulators in human diseases and to move the targets forward into drug discoveryin the multidisciplinary and global setting. The responsibility includes but not limits toindependent study design and execution, data analysis/recording/presentation, and scientific input to support the drug discovery projects. In addition to the strong can-do capability, the successful candidate should have good interpersonal skills and be the collaborative and supportive team-player.

The minimum requirement:
        Ph.D. degree in biology within 2 years with strong scientific record
        Solid technical skills in molecular and cellular biology
        Research experience in liver disease is preferred
        Experience in epigenetics or gene transcription is a plus
        Good communication skill in English

Location SH
CONTACT
florencehao@21cnmanager.com
86 21 3122 9017

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

florencehao

гæ (СÓÐÃûÆø)

ÒýÓûØÌû:
9Â¥: Originally posted by ge1983925 at 2014-02-18 14:01:57
ÊÇnovartis°É£¿ÇëÎÊ»¹ÔÚÕÐÂð£¿

florencehao@21cnmanager.com
and 021 3122 9017
»¹ÔÚÕÐŶ£¬»ðËÙºÍÎÒÁªÏµ
10Â¥2014-02-19 10:09:35
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 12 ¸ö»Ø´ð

florencehao

гæ (СÓÐÃûÆø)

urgent£¬ send email to florencehao@21cnmanager.com
4Â¥2014-01-25 09:34:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

florencehao

гæ (СÓÐÃûÆø)

still available , happy new year
5Â¥2014-02-07 17:42:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ge1983925

ľ³æ (СÓÐÃûÆø)

ÊÇnovartis°É£¿ÇëÎÊ»¹ÔÚÕÐÂð£¿
9Â¥2014-02-18 14:01:57
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ÊÕµ½¸´ÊÔµ÷¼Áµ«ÊÇÈ¥²»ÁË +8 СÎÏÅ£* 2026-04-16 8/400 2026-04-18 11:15 by zixin2025
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶294·Ö£¬Çóµ¼Ê¦ÊÕÁô +33 yzyzx 2026-04-12 37/1850 2026-04-17 23:00 by wunaiy88
[¿¼ÑÐ] 320Çóµ÷¼Á +4 Éî½¼akm 2026-04-17 4/200 2026-04-17 17:32 by Ò»ÇÐOK
[¿¼ÑÐ] 295·ÖÇóµ÷¼Á +5 ?ÒªÉϰ¶? 2026-04-17 5/250 2026-04-17 16:51 by fenglj492
[¿¼ÑÐ] Ò»Ö¾Ô¸»¦9£¬326ÇóÉúÎïѧµ÷¼Á +11 Áõīī 2026-04-13 11/550 2026-04-17 15:35 by wanganpin
[¿¼ÑÐ] ²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é +23 hualkop 2026-04-12 25/1250 2026-04-16 22:12 by SUSE_CL
[¿¼²©] É격×Ô¼ö +3 LinxiaÁÖÏÄ 2026-04-13 3/150 2026-04-16 12:55 by Ä«ºÉ֮¶
[¿¼ÑÐ] 279ѧ˶ʳƷרҵÇóµ÷¼ÁԺУ 20+7 ¹Â¶ÀµÄÀǰ®³ÔÑò 2026-04-12 29/1450 2026-04-16 09:00 by screening
[¿¼ÑÐ] 297£¬¹¤¿Æµ÷¼Á? +10 ºÓÄÏũҵ´óѧ-ÄÜ 2026-04-14 10/500 2026-04-15 21:50 by noqvsozv
[¿¼ÑÐ] Ò»Ö¾Ô¸AÇø211£¬22408 321Çóµ÷¼Á +6 ËæÐÄËùÓû¡î 2026-04-15 7/350 2026-04-15 21:45 by lbsjt
[¿¼ÑÐ] 085404 22408 309·ÖÇóµ÷¼Á +9 lzmk 2026-04-14 10/500 2026-04-15 20:02 by ѧԱJpLReM
[¿¼ÑÐ] 310Çóµ÷¼Á +16 666ÕæºÃ 2026-04-11 18/900 2026-04-15 13:28 by ºÚ¿Æ¼¼¿óÒµ
[¿¼ÑÐ] 105500ҩѧÇóµ÷¼Á +4 x_skys 2026-04-12 4/200 2026-04-14 13:37 by rndfc
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤349·ÖÇóµ÷¼Á +16 Àîľ×Ó°¡¹þ¹þ 2026-04-12 17/850 2026-04-14 09:11 by fenglj492
[¿¼ÑÐ] Çóµ÷¼Á£¬985²ÄÁÏÓ뻯¹¤348·Ö +9 º­ÖñÁõ 2026-04-11 14/700 2026-04-13 22:26 by º­ÖñÁõ
[¿¼ÑÐ] 293Çóµ÷¼Á +16 ÎÒ°®¸ßÊý¸ßÊý°®Î 2026-04-12 18/900 2026-04-13 21:47 by ѧԱJpLReM
[¿¼ÑÐ] 302Çóµ÷¼Á +10 Ò×£¡? 2026-04-13 10/500 2026-04-13 19:04 by lbsjt
[¿¼ÑÐ] 0831Ò»ÂÖµ÷¼Áʧ°ÜÇóÖú +10 СÐÜî£î£_s 2026-04-11 10/500 2026-04-12 22:43 by ³¤¹­°Á
[¿¼ÑÐ] Ò»Ö¾Ô¸Õã´óÉúÎï325·ÖÇóµ÷¼Á +9 zysheng 2026-04-12 9/450 2026-04-12 22:31 by yuyin1233
[¿¼ÑÐ] 359Çóµ÷¼Á +5 θ¾·ÂÎÀÛÁË 2026-04-11 5/250 2026-04-11 19:55 by lbsjt
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û